[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE331037T1 - Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff - Google Patents

Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Info

Publication number
ATE331037T1
ATE331037T1 AT96912605T AT96912605T ATE331037T1 AT E331037 T1 ATE331037 T1 AT E331037T1 AT 96912605 T AT96912605 T AT 96912605T AT 96912605 T AT96912605 T AT 96912605T AT E331037 T1 ATE331037 T1 AT E331037T1
Authority
AT
Austria
Prior art keywords
nucleic acid
frpb
acid molecule
isolated
corresponding vaccine
Prior art date
Application number
AT96912605T
Other languages
English (en)
Inventor
P Fredrick Sparling
Margaret Beucher
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE331037T1 publication Critical patent/ATE331037T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96912605T 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff ATE331037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41896495A 1995-04-07 1995-04-07

Publications (1)

Publication Number Publication Date
ATE331037T1 true ATE331037T1 (de) 2006-07-15

Family

ID=23660253

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912605T ATE331037T1 (de) 1995-04-07 1996-04-08 Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff

Country Status (8)

Country Link
US (3) US6265567B1 (de)
EP (1) EP0830456B1 (de)
JP (1) JP3797490B2 (de)
AT (1) ATE331037T1 (de)
AU (1) AU5537096A (de)
CA (1) CA2217522C (de)
DE (1) DE69636285D1 (de)
WO (1) WO1996031618A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
AU9363798A (en) * 1997-11-06 1999-05-31 Chiron S.P.A. Neisserial antigens
GB9808866D0 (en) * 1998-04-24 1998-06-24 Smithkline Beecham Biolog Novel compounds
BR9910005A (pt) * 1998-04-29 2001-01-16 American Cyanamid Co Composição de vacina, processos para imunização contra neisseria gonorrhoeae e para preparar uma composição de vacina, sequência de dna isolada e purificada, plasmìdeo, célula hospedeira, processo para produção de uma proteìna pilina recombinante quimérica de neisseria gonorrhoeae e neisseria meningitidis, proteìna pilina recombinante quimérica isolada e purificada de neisseria gonorhoeae e neisseria meningitidis, e, processo para imunização contra neisseria muningitidis
EP2261345A3 (de) * 1998-05-01 2012-01-11 Novartis Vaccines and Diagnostics, Inc. Antigene und Zusammensetzungen gegen Neisseria meningitidis
GB9810276D0 (en) * 1998-05-13 1998-07-15 Smithkline Beecham Biolog Novel compounds
US6692752B1 (en) 1999-09-08 2004-02-17 Smithkline Beecham Biologicals S.A. Methods of treating human females susceptible to HSV infection
EP1144643A1 (de) * 1999-01-15 2001-10-17 SMITHKLINE BEECHAM BIOLOGICALS s.a. Neisseria meningitidis antigen
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1801219B1 (de) * 1999-10-29 2015-10-14 GlaxoSmithKline Biologicals S.A. Neissersche Antigenpeptide
ES2386534T3 (es) 2000-02-28 2012-08-22 Novartis Vaccines And Diagnostics S.R.L. Expresión heteróloga de proteínas de Neisseria
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CA2493977A1 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
GB0220199D0 (en) * 2002-08-30 2002-10-09 Univ Utrecht Mutant protein and refolding method
LT1556477T (lt) 2002-11-01 2017-10-25 Glaxosmithkline Biologicals S.A. Džiovinimo būdas
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0505996D0 (en) 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
US20090246224A1 (en) 2006-06-12 2009-10-01 Nathalie Devos Vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6265567B1 (en) * 1995-04-07 2001-07-24 University Of North Carolina At Chapel Hill Isolated FrpB nucleic acid molecule

Also Published As

Publication number Publication date
DE69636285D1 (de) 2006-08-03
CA2217522C (en) 2011-09-20
WO1996031618A1 (en) 1996-10-10
JP3797490B2 (ja) 2006-07-19
EP0830456A4 (de) 2001-03-14
US20030096368A1 (en) 2003-05-22
CA2217522A1 (en) 1996-10-10
US20050271681A1 (en) 2005-12-08
US6265567B1 (en) 2001-07-24
EP0830456A1 (de) 1998-03-25
JPH11503322A (ja) 1999-03-26
AU5537096A (en) 1996-10-23
EP0830456B1 (de) 2006-06-21

Similar Documents

Publication Publication Date Title
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
DK0758248T3 (da) Formuleringer til faktor IX
ATE216590T1 (de) Arzneimittelformulierungen für il-12
NO20042298L (no) Farmasoytiske preparater og deres anvendelser
ATE196913T1 (de) Neuartige peptidderivate
DK1200418T3 (da) Nematodicide trifluorbutener
TR200101867T2 (tr) CCR5 modülatörleri olarak piperidinler
NO983999L (no) Peptidimmunogener for vaksinasjon mot og behandling av allergi
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
IL189629A0 (en) Compositions containing human ctla-4 antibodies
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
CY1105235T1 (el) Συνθεσεις λασοφοξιφενης
DK0705100T3 (da) Terapeutiske substituerede guanidiner
ATE210988T1 (de) Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
ATE203519T1 (de) Chinolinderivate als antimalariamittel
PT789590E (pt) Imunopotenciacao induzida por quitosano
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
AU6415994A (en) Substituted caprolactams and derivatives thereof useful for treatment of hiv disease
ATE201693T1 (de) Hämoregulierende peptide
AU5163598A (en) Novel hepatitis b inhibitors
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
DE69619123D1 (de) Hämoregulatorische verbindungen
DK0579765T3 (da) Fremgangsmåde og præparat til behandling af herpes-relaterede sygdomme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties